Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dihydrotestosterone (DHT) is a potent androgen synthesized from testosterone by the enzyme 5α-reductase. It plays a crucial role in male sexual development, prostate growth, and hair growth. While not directly targeted by drugs, its synthesis is often inhibited to treat conditions like benign prostatic hyperplasia and androgenic alopecia. DHT exerts its effects primarily by binding to and activating the androgen receptor.
DHT itself is not directly targeted by drugs, but its synthesis is inhibited, or its receptor is blocked
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dihydrotestosterone (DHT).